Loss is ubiquitous in old age, yet prevalence of major depressive disorder (MDD) and dysthymia is lower than in younger adults
Proposed reasons
Rarity of late-onset depression
Higher mortality among depressed persons
Fewer disorders precipitated by emotional upheaval or substance abuse
Presentation of depression differs
Prominent physical complaints or cognitive changes → may mimic dementia
Suicide incidence in elders: 40/100{,}000 (highest in older White men)
Survivors’ attributions differ by gender of decedent
Male suicide → assumed physical illness
Female suicide → assumed mental illness
Close link between physical & mental health
Emotional problems worsen the course of chronic medical illness
Most common: depressive disorders, cognitive disorders, phobias, alcohol use disorders
High risk for
Suicide
Drug-induced psychiatric symptoms
Many disorders are preventable, reversible, or ameliorable, esp. delirium & some dementias
Comprehensive battery preferred, though multi-hour testing may be impractical
Domains & representative tests
Gross cognition: Mini-Mental State Examination (MMSE)
Intelligence: WAIS-R / WAIS-III
Basic attention: WAIS Digit Span
Processing speed: WAIS Digit Symbol, Trailmaking A, Stroop A/B
Motor dexterity: Finger tapping (right & left)
Language: Boston Naming Test; WAIS Vocabulary
Visual–perceptual/spatial: WAIS Picture Completion, Block Design; Rey–Osterrieth copy; Beery VMI
Learning & memory: 8- to 10-word list; WMS Logical Memory & Visual Reproduction; Rey–Osterrieth recall
Executive functions: Trailmaking B; Stroop C; Wisconsin Card Sorting; Verbal fluency (FAS/category); Design fluency
Psychosocial risks: loss of roles/autonomy, bereavement, health decline, isolation, finances, ↓ cognition
Drug-induced symptoms caused by
Age-related pharmacokinetic changes
Excess dose / non-adherence / poly-prescribing
Hypersensitivity
Nearly entire spectrum of psychiatric disorders can be drug-induced
Second only to arthritis as a cause of disability >65 y
Prevalence ≥65 y: severe dementia 5\%; mild 15\%
≥80 y: severe \approx 20\%
Risk factors: age, family history, female sex
Clinical picture
Gradual loss of previously attained functions
Cognitive, memory, language, visuospatial deficits; behavioral issues (agitation, wandering, disinhibition, sleep issues, delusions/hallucinations in \approx 75\%)
Potentially treatable in 10\text{–}15\% (e.g.
Systemic: heart, renal, CHF
Endocrine: hypo-thyroid
Vit.
Drug misuse
Depression)
Cortical vs. subcortical classification
Subcortical: Huntington, Parkinson, NPH, vascular, Wilson → movement disorders, gait apraxia, apathy, akinetic mutism (may mimic catatonia)
Cortical: Alzheimer, CJD, Pick → aphasia, agnosia, apraxia
Prion diseases
Familial CJD, Gerstmann–Sträussler–Scheinker, fatal familial insomnia (AD inheritance, PRNP mutation)
Acquired: kuru (Fore cannibalism), iatrogenic (grafts, cadaveric hormones)
Sporadic CJD: \approx 1/1{,}000{,}000 annually; mean onset 65 y; rare <30 y
Prevalence: \approx 15\% of community & nursing-home elders have depressive symptoms
Risk factors: widowhood, chronic medical illness (age per se not a risk)
High recurrence in late-onset cases
Symptoms: ↓ energy/concentration, sleep fragmentation (esp. early awakening), ↓ appetite, weight loss, somatic focus
Melancholic features more common: hypochondriasis, worthlessness, sex/sin guilt, paranoia, suicidality
Depression-related cognitive dysfunction (“pseudodementia”)
Occurs in \approx 15\% of depressed elders
Distinguish from degenerative dementia
Variable attention; “I don’t know” responses; recognition > free recall; minimal language impairment/confabulation
Yet 25\text{–}50\% of neurodegenerative dementia patients are concurrently depressed
Geriatric Depression Scale (15-item short form); score >5 ⇒ probable depression
Typically begins in youth; first diagnosis >65 y rare
Late-onset (after 45 y) described; more common in women; predominantly paranoid subtype
Prognosis
20\% symptom-free by 65 y
80\% residual impairment; psychopathology diminishes with age
Residual subtype in \approx 30\% (negative symptoms dominate) → often requires long-term hospitalization
Elders respond to antipsychotics but need lower doses
Onset usually 40–55 y but possible at any geriatric age
Forms
Persecutory (most common): spying, poisoning, harassment → potential violence or reclusiveness
Somatic: conviction of fatal illness
Prevalence of pervasive persecutory ideation >65 y: \approx 4\%
Triggers: spousal death, retirement, isolation, finance, medical illness, sensory loss
Rule out dementia, mood disorders, schizophrenia, substance/med-induced, tumors
Prognosis fair–good; best with psychotherapy + pharmacotherapy
Paraphrenia: late-onset persecutory delusions (>60 y) without dementia; possibly schizophrenia variant; ↑ if FHx schizophrenia
1-month prevalence ≥65 y: 5.5\% (ECA)
Phobias: 4\text{–}8\% (most common)
Panic disorder: 1\% (new-onset rare)
Impact: milder signs yet equally or more disabling due to mobility limits
Existential factors: confronting mortality; Erikson’s integrity vs. despair
PTSD more severe owing to comorbid physical illness
OCD may first appear in late life, though many had obsessive-compulsive personality traits earlier
Features: ego-dystonic rituals/obsessions → rigidity, checking, orderliness
Somatic complaints common: >80\% of >65 y have ≥1 chronic illness (arthritis, CV disease)
After 75 y: 20\% have diabetes; average 4 chronic conditions
Hypochondriasis prevalent >60 y (peak 40–50 y); chronic, guarded prognosis
Management: frequent but low-risk examinations; validate pain; avoid unnecessary invasive tests; employ psychologic/pharm interventions
Alcohol dependence often longstanding from youth/midlife
Typical elder drinker: medically ill (liver), divorced/widowed/never-married male, arrests, homelessness, Wernicke–Korsakoff
Nursing home prevalence: 20\% alcohol dependence
Overall, substance disorders = 10\% of geriatric emotional problems; hypnotic, anxiolytic, narcotic dependence under-recognized
Presentation: confusion, poor hygiene, depression, malnutrition, falls, exposure
Hospital delirium → often alcohol withdrawal
Consider abuse in chronic GI issues
OTC misuse: analgesics (35 %), laxatives (30 %); nicotine, caffeine
Age is main risk factor; elders report ↓ sleep quality, ↑ daytime naps, ↑ hypnotic use
Higher rates of
Breathing-related sleep disorder
Medication-induced movement disorders
Primary sleep disorders
Dyssomnias: primary insomnia, nocturnal myoclonus, restless legs, sleep apnea
Parasomnias: REM sleep behavior disorder (almost exclusively older men)
Contributing factors: pain, nocturia, dyspnea, GERD, lack of routine, institutionalization, alcohol
Pharmacologic caveats: monitor for anterograde amnesia, residual sedation, rebound insomnia, gait instability
Sleep architecture changes ≥65 y
REM: redistributed, ↑ episodes, shorter duration, ↓ total REM
NREM: ↓ delta amplitude, ↓ stages 3–4, ↑ stages 1–2, ↑ awakenings
Circadian: ↓ amplitude, 12-h sleep-propensity rhythm, shorter cycles; ↓ melatonin, altered adenosine response
Highest of any age group; white men >65 y have rate ≈5\times general population
Reasons reported by suicidal elders
\approx 33\% loneliness
\approx 10\% each: finances, poor health, depression
Demographics
Completions: 60\% male; attempts: 75\% female
Methods: completions → firearms/hanging; attempts → 70\% overdose, 20\% cutting
Most completers had unrecognized psychiatric disorder (mainly depression)
Precipitants: illness & loss (elders) vs. job/finance/family (younger)
Many communicate intent; clinicians must inquire directly—no evidence of iatrogenic suggestion
Common → activity avoidance/fear of falls
Etiologies: anemia, hypotension, arrhythmia, cerebrovascular, basilar insufficiency, ear disease, acoustic neuroma, benign positional vertigo, Ménière
Often psychological component; assess secondary gain
Anxiolytic overuse ⇒ dizziness
Tx: meclizine 25\text{–}100\,\text{mg}/day
Mechanism: transient cerebral hypoperfusion → LOC
Requires full medical work-up
Causes (Table 25-6)
Cardiac: structural (aortic stenosis, mitral prolapse/regurgitation, HCM, myxoma); electrical (tachy-, brady-arrhythmias, block, sick sinus); ischemia/infarct
Situational hypotension: dehydration, orthostatic, postprandial, micturition, defecation, cough, swallow
Reflex: carotid sinus, vasovagal
Drugs: vasodilators, CCBs, diuretics, \beta-blockers
CNS: cerebrovascular insuff., seizures
Metabolic: hypoxemia, glucose extremes, anemia
Pulmonary: COPD, pneumonia, PE
Prevalence
≥65 y: \approx 30\%
≥75 y: \approx 50\%
Clue: “I can hear but not understand.” Most benefit from hearing aids
Affects \approx 10\% >65 y
Defined (AMA): act/omission causing harm/threatened harm
Physical, psychological, financial, material, sexual abuse; neglect (withholding necessities)
Victims: very old, frail, co-reside with often dependent abuser; both parties minimize
Interventions: legal, housing, medical, psychiatric, social services
Widowhood prevalence ≥65 y: women 51\%, men 14\%
Highly stressful; depressive sx peak within months, usually decline ≤1 y
↑ Mortality among survivors; highest in those with psychiatric illness or spouse’s suicide
Goals: improve quality of life, keep patients in community, postpone nursing-home placement
Pre-treatment assessment: full medical exam + ECG; collect all current meds (polypharmacy)
Dosing guidelines
Divide total daily dose (3–4×) to avoid peaks (except bedtime dosing for hypnotic effect)
Use liquids if swallowing issues
Monitor BP, pulse, side-effects
Frequent reassessment; attempt washout & baseline re-eval when possible
Epidemiology of drug use
≥65 y: highest medication users (25 % of Rx’s)
\approx 250{,}000 U.S. hospitalizations/yr from adverse drug reactions
Psychotropics, CV, diuretics most common; 40 % of hypnotics dispensed to >75 y
OTC usage: 70\% elders vs. 10\% young adults
Pharmacokinetic considerations
↓ renal & hepatic clearance (renal, liver, CV disease)
↓ gastric acid affects absorption
Body composition: ↓ lean, ↑ fat → prolonged action of lipid-soluble drugs
Altered receptor sensitivity (e.g., ↑ orthostatic hypotension)
Core rule: “Start low, go slow.” Use minimal effective dose; know interactions
Modalities: insight-oriented, supportive, cognitive, group, family; psychoanalysis possible if appropriate
Targets age-related issues
Adapting to multiple losses (friends, roles)
New roles (retirement)
Acceptance of mortality
Benefits
↑ interpersonal functioning, self-esteem, confidence
↓ helplessness, anger; ↑ quality of life
Can improve physical sx (e.g., urinary incontinence, gait, alertness) even in cognitively impaired
Therapeutic stance
More active, supportive, flexible; anticipate need to liaise with physicians/family when incapacity arises
Elders may idealize therapist; gradual collaboration encouraged; sometimes therapist must maintain an idealized role to permit progress.